[Federal Register Volume 73, Number 86 (Friday, May 2, 2008)]
[Notices]
[Page 24291]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-9671]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Development, Implementation and Evaluation of 
Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community 
and Healthcare Settings, Funding Opportunity Announcement (FOA) CI08-
001

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 12 p.m.-3 p.m., May 20, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
``Development, Implementation and Evaluation of Novel Strategies To 
Reduce Inappropriate Antimicrobial Use in Community and Healthcare 
Settings,'' FOA CI08-001.
    Contact Person for More Information: Christine Morrison, PhD, 
Scientific Review Administrator, Office of the Chief Science 
Officer, CDC, 1600 Clifton Road, NE., Mailstop D74, Atlanta, GA 
30333, Telephone 404-639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 28, 2008.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E8-9671 Filed 5-1-08; 8:45 am]
BILLING CODE 4163-18-P